YTE reported $2.44B in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Agenus AGEN:US $ 228.38M 19.32M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Amgen AMGN:US $ 5203M 1325M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Chemocentryx CCXI:US $ 44.4M 3.82M
Clovis Oncology CLVS:US $ 94.58M 27.66M
Cti Biopharma CTIC:US $ 66.09M 30.81M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Exelixis EXEL:US $ 627M 96.27M
Gilead Sciences GILD:US $ 7000M 2704M
Idera Pharmaceuticals IDRA:US $ 24.48M 3.51M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Macrogenics MGNX:US $ 21.47M 25.86M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Newlink Genetics NLNK:US $ 86.76M 8.05M
Novartis NOVN:VX SF 3625M 10227M
Novartis NVS:US $ 3625M 10227M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Seattle Genetics SGEN:US $ 364.87M 103.88M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
YTE INCY:US $ 2435.38M 178.62M